-
公开(公告)号:US20220387428A1
公开(公告)日:2022-12-08
申请号:US17644045
申请日:2021-12-13
Applicant: Novartis AG
Inventor: Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy Brian HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
IPC: A61K31/501 , A61P21/00 , A61K31/502 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K45/06 , C07D237/20 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/08 , C07D471/10 , C07D487/04 , C07D487/10 , A61K31/41 , A61K31/427 , C07D237/06
Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
-
公开(公告)号:US20250092042A1
公开(公告)日:2025-03-20
申请号:US18924066
申请日:2024-10-23
Applicant: NOVARTIS AG
Inventor: Mallesh BUSHABOINA , Xin CHEN , Atwood Kim CHEUNG , Andrew James CULSHAW , Timothy Brian HURLEY , Nancy LABBE-GIGUERE , Wolfgang MILTZ , David ORAIN , Tajesh PATEL , Srinivasan RAJAGOPALAN , Till ROEHN , David Andrew SANDHAM , Gebhard THOMA , Ritesh Bhanudasji TICHKULE , Rudolf WÄLCHLI
IPC: C07D471/10 , A61K45/06 , C07D519/00
Abstract: The present invention provides a method for manufacturing a compound of formula (I) or a pharmaceutically acceptable salt thereof; wherein R1 R2, R4 and X1 are defined herein.
-
3.
公开(公告)号:US20240009189A1
公开(公告)日:2024-01-11
申请号:US18322521
申请日:2023-05-23
Applicant: Novartis AG
Inventor: Atwood Kim CHEUNG , Natalie Alysia DALES , Timothy Brian HURLEY
IPC: A61K31/501 , C07D405/14 , C07D401/04 , C07D487/10 , A61K31/517 , C07D413/14 , C07D487/04 , A61K31/5377 , C07D401/14 , A61K31/502
CPC classification number: A61K31/501 , C07D405/14 , C07D401/04 , C07D487/10 , A61K31/517 , C07D413/14 , C07D487/04 , A61K31/5377 , C07D401/14 , A61K31/502
Abstract: The present invention provides a compound of formula IA or a pharmaceutically acceptable salt thereof;
a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.-
4.
公开(公告)号:US20200345732A1
公开(公告)日:2020-11-05
申请号:US16934787
申请日:2020-07-21
Applicant: Novartis AG
Inventor: Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy Brian HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
IPC: A61K31/501 , A61K31/502 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K45/06 , C07D237/20 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/08 , C07D471/10 , C07D487/04 , C07D487/10 , A61K31/41 , A61K31/427 , C07D237/06
Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
-
5.
公开(公告)号:US20190160062A1
公开(公告)日:2019-05-30
申请号:US16259441
申请日:2019-01-28
Applicant: Novartis AG
Inventor: Atwood Kim CHEUNG , Natalie DALES , Timothy Brian HURLEY
IPC: A61K31/501 , A61K31/5377 , A61K31/517 , C07D487/04 , C07D401/14 , C07D413/14 , C07D405/14 , C07D401/04
Abstract: The present invention provides a compound of formula IA or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
-
公开(公告)号:US20240043425A1
公开(公告)日:2024-02-08
申请号:US18319585
申请日:2023-05-18
Applicant: NOVARTIS AG
Inventor: Mallesh BUSHABOINA , Xin CHEN , Atwood Kim CHEUNG , Andrew James CULSHAW , Timothy Brian HURLEY , Nancy LABBE-GIGUERE , Wolfgang MILTZ , David ORAIN , Tajesh PATEL , Srinivasan RAJAGOPALAN , Till ROEHN , David Andrew SANDHAM , Gebhard THOMA , Ritesh Bhanudasji TICHKULE , Rudolf WÄLCHLI
IPC: C07D471/10 , A61K45/06 , C07D519/00
CPC classification number: C07D471/10 , C07D519/00 , A61K45/06
Abstract: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof;
wherein R1 R2, R4 and X1 are defined herein, a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.-
7.
公开(公告)号:US20190358226A1
公开(公告)日:2019-11-28
申请号:US16237907
申请日:2019-01-02
Applicant: Novartis AG
Inventor: Atwood Kim CHEUNG , Donovan Noel CHIN , Natalie DALES , Aleem FAZAL , Timothy Brian HURLEY , John KERRIGAN , Gary O'BRIEN , Lei SHU , Robert SUN , Moo Je SUNG
IPC: A61K31/501 , A61K31/427 , C07D487/10 , A61K31/502 , A61K31/506 , A61K31/5377 , A61K31/551 , C07D237/06 , C07D487/04 , A61K45/06 , C07D237/20 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D471/08 , C07D471/10 , A61K31/41
Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
-
-
-
-
-
-